Online Exclusives

Cold Chain Management | Information Technology | Supply Chain

Cold Chain Technology Trends

What are the best features of a cold chain data logger?

Emily Newton, Contributing Writer 11.22.22

Biologics, Proteins, Vaccines | Clinical Trials

Responsive Strategies in Vaccine Development

The importance of disease surveillance, developments in early outbreak detection, and the role of smart data reporting and adaptive trial designs.

Kristin Brooks, Managing Editor, Contract Pharma 11.21.22

Clinical Trials | Drug Development

Functional Service Partnerships: Speeding Seamless Implementation

Establishing an FSP model, managing challenges, and how the role of implementation lead can assure efficient onboarding and resourcing for research projects.

Kristin Brooks, Managing Editor, Contract Pharma 11.17.22

APIs | Cytotoxics and High Potency Manufacturing

Challenges of Preparing Highly Potent Oral Products

Developing highly potent APIs requires comprehensive attention to risk management, facilities, equipment, and personnel.

Albert Seda and Carolina Bonifacio, Siegfried 11.01.22

APIs | Drug Development

Leveraging Fermentation to Produce Complex APIs

Enabling more resilient, sustainable supply chains for drugs and essential medicines.

Kristin Brooks, Managing Editor, Contract Pharma 10.31.22

Fill/Finish | Injectables | Vials

Packaging Today's Specialized Drug Products

Deborah Smook of TurboFil Packaging Machines discusses today’s manufacturing equipment trends and some of the latest advances.

Kristin Brooks, Managing Editor, Contract Pharma 10.19.22

Biologics, Proteins, Vaccines

Monoclonal Antibodies (mAbs): An Overview

What are mAbs, how are they made, and what’s the market for these therapies?

10.17.22

QA/QC

Quality Assurance for Pharmaceuticals

Top 4 ways to increase quality in pharmaceutical manufacturing and distribution.

Emily Newton, Contributing Writer 10.07.22

Clinical Trials

DCTs Deliver Measurable Benefits for Sponsors: Global Analysis Findings

Multiple benefits impacting trial timelines and related cost with notable reductions in protocol deviations rate, recruitment times, and first patient in.

Bhausaheb Patil, Head of Business Operations, Decentralized Clinical Trials, IQVIA 10.06.22

Supply Chain

Reimagining the Future of Pharma Supply Chains

Confronting challenges ranging from surging demand for vital medical products to shortages of critical items.

Olaf Zweig, EY Partner, Life Sciences , Derron Stark, EY Principal, Strategy and Transactions 10.05.22

Solid Dosage/Creams/Ointments

Amorphous Solid Dispersions for Bioavailability Enhancement

Advances in ASD formulation development and analytical techniques are helping to improve patient outcomes.

Deanna Mudie, Lonza 09.15.22

Biologics, Proteins, Vaccines | cGMP Manufacture | Fill/Finish

Sterile Manufacturing Trends & Overcoming Challenges

Sterile biologics R&D, new delivery platforms for complex APIs, and single use technologies drive outsourcing.

Kristin Brooks, Managing Editor, Contract Pharma 09.08.22

Biologics, Proteins, Vaccines | Clinical Trials | Drug Development

Cell and Gene R&D in Cancer Care: Increasing Patient Access

The latest in CAR-T therapies including manufacturing, storage and supply chain, and dose optimization in early phase oncology.

David Alsadius, Jeffrey Hodge, and Erin Finot, IQVIA 09.06.22

Analytical Services | Drug Development | Laboratory Testing | R&D

Pharmacovigilance Outsourcing: Ensuring a Positive Experience

Current outsourcing practices, tips for selecting a service provider, and ensuring a successful relationship.

Karen Johnstone and Sabine Richter, ICON 08.22.22

"3 Key Trends" with Stuart Needleman

Piramal Pharma Solutions' Chief Commercial Officer offers his thought leadership.

08.18.22

Biologics, Proteins, Vaccines

“3 Key Trends” with James Park

Samsung Biologics' EVP and Chief Business Officer offers his thought leadership.

08.10.22

Biologics, Proteins, Vaccines

Why Are More Biopharmaceutical Manufacturers Outsourcing Production?

Opportunities for CDMOs in the biomanufacturing segment are abundant and will continue to be for the foreseeable future.

Emily Newton, Contributing Writer 08.10.22

Clinical Trials | Information Technology

Behind Every Successful eCOA Solution is a Robust Scientific Strategy

While increased adoption of eCOAs has made patient centricity a key priority in clinical trial designs, an eCOA solution depends on the scientific strategy.

Melissa Mooney, Director of eCOA Solutions Engineering, IQVIA 08.10.22

Drug Development | Information Technology